Iain Dukes is the CEO at Viriom. Previously, Iain was an SVP of Licensing & External Science at Merck. Iain holds an M.A. in Jurisprudence (Law) from the University of Oxford.
This person is not in any offices
Viriom
Viriom is a commercial and late development stage biotech company developing novel therapies and prevention treatments against HIV and hepatitis B virus (HBV).